UA100672C2 - HUMANIZED ANTIBODY TO b-AMYLOID PROTEIN - Google Patents
HUMANIZED ANTIBODY TO b-AMYLOID PROTEINInfo
- Publication number
- UA100672C2 UA100672C2 UAA200900880A UAA200900880A UA100672C2 UA 100672 C2 UA100672 C2 UA 100672C2 UA A200900880 A UAA200900880 A UA A200900880A UA A200900880 A UAA200900880 A UA A200900880A UA 100672 C2 UA100672 C2 UA 100672C2
- Authority
- UA
- Ukraine
- Prior art keywords
- amyloidosis
- amyloid
- disease
- diseases
- dementia
- Prior art date
Links
Abstract
The invention relates to a humanized antibody or a fragment thereof, which specifically binds to at least one epitope on the β-amyloid protein. The invention further relates to a pharmaceutical composition, test kit, nucleic acid molecule, expression vector, host cell, a method for producing the composition, method of diagnosis of an amyloid-associated disease or condition, method of determining the extent of amyloidogenic plaque burden in a tissue sample, method for preventing, treating or alleviating the effects of one or more amyloidosis-related diseases, methods and compositions for preventing or addressing the complications associated with amyloidosis, a group of diseases and disorders associated with amyloid plaque formation including secondary amyloidosis and age-related amyloidosis including, but not limited to, neurological disorders such as Alzheimer's Disease (AD), Lewy body dementia, Down's syndrome, hereditary cerebral hemorrhage with amyloidosis (Dutch type); the Guam Parkinson-Dementia complex; as well as other diseases which are based on or associated with amyloid-like proteins such as progressive supranuclear palsy, multiple sclerosis; Creutzfeld Jacob disease, Parkinson's disease, HIV-related dementia, ALS (amyotropic lateral sclerosis), Adult Onset Diabetes; senile cardiac amyloidosis; endocrine tumors, and others, including macular degeneration.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06014730 | 2006-07-14 | ||
PCT/US2007/073504 WO2008011348A2 (en) | 2006-07-14 | 2007-07-13 | Humanized antibody against amyloid beta |
Publications (1)
Publication Number | Publication Date |
---|---|
UA100672C2 true UA100672C2 (en) | 2013-01-25 |
Family
ID=41040485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200900880A UA100672C2 (en) | 2006-07-14 | 2007-07-13 | HUMANIZED ANTIBODY TO b-AMYLOID PROTEIN |
Country Status (3)
Country | Link |
---|---|
AR (2) | AR107315A2 (en) |
UA (1) | UA100672C2 (en) |
ZA (1) | ZA200900313B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9573994B2 (en) * | 2014-07-10 | 2017-02-21 | Bioarctic Neuroscience Ab | Aβ protofibril binding antibodies |
-
2007
- 2007-07-13 UA UAA200900880A patent/UA100672C2/en unknown
-
2009
- 2009-01-14 ZA ZA200900313A patent/ZA200900313B/en unknown
-
2017
- 2017-01-06 AR ARP170100039A patent/AR107315A2/en unknown
-
2018
- 2018-08-21 AR ARP180102374A patent/AR112975A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR107315A2 (en) | 2018-04-18 |
AR112975A2 (en) | 2020-01-15 |
ZA200900313B (en) | 2010-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6795649B2 (en) | Immunological targeting method for pathological tau protein | |
WO2007068412A3 (en) | A beta 1-42 specific monoclonal antibodies with therapeutic properties | |
KR101783058B1 (en) | Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide | |
Schmidt et al. | Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease | |
US20230295283A1 (en) | N-terminal truncated protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's | |
WO2008060364A3 (en) | Humani zed antibody against amyloid beta | |
MX2009013503A (en) | Monoclonal anti beta amyloid antibody. | |
MX2009003468A (en) | Antibodies. | |
NZ738595A (en) | Antibodies specific for hyperphosphorylated tau and methods of use thereof | |
BRPI0709050A2 (en) | antibody or fragment thereof, composition, methods for preventing or treating, and for diagnosing disorders, methods for detecting ab protofibrils in vitro, and use of the antibody | |
EP2356144B1 (en) | Composition for producing antibodies binding to anti-amyloid beta peptide with d-peptides | |
EP1978035A1 (en) | Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases | |
UA102368C2 (en) | SPECIFIC IN RELATION b-AMYLOID 1-42 MONOKLONAL'NI ANTIBODIES WHICH ARE THERAPEUTIC CHARACTERISTICS | |
UA100672C2 (en) | HUMANIZED ANTIBODY TO b-AMYLOID PROTEIN | |
JP2022528459A (en) | Fusion constructs and their use | |
EP3126839B1 (en) | Agents useful in diagnostic and therapy of beta-amyloid aggregation related disorders and screening methods | |
WO2001090187A3 (en) | G-protein coupled olfactory receptors | |
WO2005003288A3 (en) | Diagnostic methods , prognostic methods and pharmaceutical compositions for neurodegenerative diseases like alzheimer’s disease by modulating and investigating genes rgs4 and itpkb, their gene products or fragments and derivatives thereof | |
ES2356159T3 (en) | SELECTED ANTIBODIES OF IMPROVED PROTOFIBRILLES AND THEIR USE. |